穩定同位素標記化合物市場 - 全球規模、佔有率、趨勢分析、機會、預測報告，2019-2029

到 2029 年，穩定同位素標記化合物的全球市場規模將達到 3.97 億美元

由於製藥和生物技術領域的研發活動活性化以及人們對治療越來越多疾病的興趣日益濃厚，全球穩定同位素標記化合物市場正在蓬勃發展。

領先的策略諮詢和市場研究公司 BlueWeave Consulting 在最近的一項研究中估計，2022 年全球穩定同位素標記化合物市場規模為 3.035 億美元。 BlueWeave 預測，在 2023-2029 年預測期內，全球穩定同位素標記化合物市場規模將以 3.9% 的年複合成長率成長，並於 2029 年達到 3.9671 億美元。全球穩定同位素標記化合物市場的主要成長促進因素包括研究活動的快速成長以及製藥和生物技術領域分析研究的上升趨勢。癌症罹患率的增加極大地促進了使用穩定同位素標記化合物的分析研究。該市場預計將成長，主要是由於對分析活動的需求不斷增加，特別是在個人化醫療和製藥領域。這種融合代表著市場的強勁成長機會。 2022年，美國新發癌症病例約191萬例，尤其影響生殖及消化器官系統，進一步凸顯市場潛力。與蛋白質體學研究類似，穩定同位素示蹤在了解營養補充食品癌症代謝的影響方面的作用有助於市場擴張。這些進步支持了市場強勁成長的預期。然而，穩定同位素標記化合物的高成本和缺乏熟練專業人員預計將限制預測期內的整體市場成長。

該報告的詳細分析提供了有關全球穩定同位素標記化合物市場的成長潛力、未來趨勢和統計數據的資訊。它還涵蓋了推動市場總規模預測的要素。該報告致力於提供全球穩定同位素標記化合物市場的最新技術趨勢和產業見解，以幫助決策者做出明智的策略決策。此外，我們也分析了市場的成長促進因素、挑戰和競爭力。

目錄

第1章 研究框架

第2章 執行摘要

第3章 全球穩定同位素標記化合物市場洞察

• 產業價值鏈分析
• DROC分析
  • 成長促進因素
    • 製藥和生物技術領域的研究活動增加
    • 疾病傳播增加
  • 抑制因素
    • 穩定同位素標記化合物的成本高
    • 缺乏熟練的專業人員
  • 機會
    • 製藥業的成長
    • 新申請
  • 任務
    • 生產複雜性
    • 競爭
• 科技進步/最新發展
• 法律規範
• 波特五力分析

第4章 全球穩定同位素標記化合物市場概況

• 2019-2029年市場規模及預測
  • 按金額
• 市佔率及預測
  • 按類型
    • 氘
    • 氧18
    • 碳13
    • 氮15
  • 按用途
    • 醫學診斷
    • 工業的
    • 調查
    • 其他
  • 按最終用戶
    • 學術/研究機構
    • 醫院和診斷中心
    • 製藥和生物技術公司
    • 其他
  • 按地區
    • 北美洲
    • 歐洲
    • 亞太地區 (APAC)
    • 拉丁美洲 (LATAM)
    • 中東和非洲 (MEA)

第5章 北美穩定同位素標記化合物市場

• 2019-2029年市場規模及預測
  • 按金額
• 市佔率及預測
  • 按類型
  • 按用途
  • 按最終用戶
  • 按國家/地區
    • 美國
    • 加拿大

第6章 歐洲穩定同位素標記化合物市場

• 2019-2029年市場規模及預測
  • 按金額
• 市佔率及預測
  • 按類型
  • 按用途
  • 按最終用戶
  • 按國家/地區
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 比利時
    • 俄羅斯
    • 荷蘭
    • 其他歐洲國家

第7章 亞太穩定同位素標記化合物市場

• 2019-2029年市場規模及預測
  • 按金額
• 市佔率及預測
  • 按類型
  • 按用途
  • 按最終用戶
  • 按國家/地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲和紐西蘭
    • 印尼
    • 馬來西亞
    • 新加坡
    • 越南
    • 亞太地區其他國家

第8章 拉丁美洲穩定同位素標記化合物市場

• 2019-2029年市場規模及預測
  • 按金額
• 市佔率及預測
  • 按類型
  • 按用途
  • 按最終用戶
  • 按國家/地區
    • 巴西
    • 墨西哥
    • 阿根廷
    • 秘魯
    • 拉丁美洲其他地區

第9章 中東和非洲穩定同位素標記化合物市場

• 2019-2029年市場規模及預測
  • 按金額
• 市佔率及預測
  • 按類型
  • 按用途
  • 按最終用戶
  • 按國家/地區
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 科威特
    • 南非
    • 奈及利亞
    • 阿爾及利亞
    • MEA 的其餘部分

第10章 競爭形勢

• 主要企業及其產品列表
• 2022 年全球穩定同位素標記化合物市場佔有率分析
• 透過管理參數進行競爭基準化分析
• 主要策略發展（合併、收購、合作夥伴關係等）

第11章COVID-19 對全球穩定同位素標記化合物市場的影響

12：公司簡介（公司簡介、財務矩陣、競爭形勢、關鍵人員、主要競爭、聯絡地址、策略展望、SWOT分析）

• TAIYO NIPPON SANSO CORPORATION
• PerkinElmer Inc.
• Alsachim
• Isoflex
• Merck KGaA
• URENCO
• 3C Molecular
• Trace Sciences International
• Cambridge Isotope Laboratories, Inc.
• IsoSciences, LLC
• Medical Isotopes, Inc.
• Omicron Biochemicals, Inc.
• 其他主要企業

第13章關鍵戰略建議

第14章調查方法

Global Stable Isotope Labeled Compounds Market Size Set to Touch USD 397 Million by 2029.

Global stable isotope labeled compounds market is flourishing because of an increasing research and development activities in the pharmaceutical and biotechnology sector and growing focus on treating the increasing prevalence of diseases.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the global stable isotope labeled compounds market size at USD 303.5 million in 2022. During the forecast period between 2023 and 2029, BlueWeave expects the global stable isotope labeled compounds market size to grow at a CAGR of 3.9% reaching a value of USD 396.71 million by 2029. Major growth drivers for the global stable isotope labeled compounds market include an increasing surge in research activities and growing trend in analytical research within the pharmaceutical and biotechnology sector. The rising incidence of cancer has notably boosted analytical investigations using stable isotope-labeled compounds. The market is set to thrive, primarily due to increasing demand for analytical activities, particularly in personalized medicine and pharmaceuticals. This convergence presents an opportunity for strong market growth. In 2022, the United States witnessed around 1.91 million new cancer cases, notably affecting the genital and digestive systems, further emphasizing the market's potential. Stable isotope tracing's role in understanding nutraceuticals' impact on cancer metabolism, as well as proteomics research, contributed to market expansion. These advances supported expectations of robust market growth. However, high cost of stable isotope labeled compounds and lack of skilled professionals are anticipated to restrain the overall market growth during the forecast period.

Global Stable Isotope Labeled Compounds Market - Overview:

Stable isotope labeling involves the utilization of non-radioactive isotopes as tracers for modeling various chemical and biochemical systems. These isotopes function as distinctive markers for compounds, detectable through techniques such as nuclear magnetic resonance (NMR) and mass spectrometry (MS). Commonly employed stable isotopes encompass 2H, 13C, and 15N. Researchers, particularly those engaged in metabolism-mediated toxicity studies, have shown significant interest in stable isotope-labeled compounds. Their significance has grown substantially in assessing in vivo metabolism across a wide spectrum of metabolic investigations. Beyond metabolomics research, stable isotope-labeled compounds are experiencing increasing utilization in environmental analysis, proteomics, and medical diagnostic research.

Impact of COVID-19 on Global Stable Isotope Labeled Compounds Market:

COVID-19 pandemic had a positive impact on the global stable isotope labeled compounds market. The emergence of the pandemic prompted a surge in research and development efforts worldwide as companies and institutions sought to combat the virus and devise effective management strategies. During the pandemic period, the global stable isotope labeled compounds market experienced noteworthy growth due to heightened demand for stable isotope-labeled compounds, driven by their crucial role in research related to the virus, such as investigations into the structure and dynamics of membrane proteins in pathogens like SARS-CoV-2. As the acute phase of the pandemic subsided, the market transitioned into a post-pandemic phase, and it is expected to continue its growth trajectory. The lessons learned and the increased utilization of stable isotope-labeled compounds during the pandemic are likely to contribute to healthy market expansion during the forecast period.

Global Stable Isotope Labeled Compounds Market - By End User:

On the basis of end user, the global stable isotope labeled compounds market is divided into Academic & Research Institutions, Hospital & Diagnostic Centers, and Pharmaceutical & Biotechnology Companies segments. The pharmaceutical & biotechnology companies segment is expected to hold the highest share in the global stable isotope labeled compounds market by end user during the forecast period. These industries heavily rely on stable isotopes for drug discovery, development, and toxicity studies. Additionally, the growing focus on precision medicine and personalized therapies has intensified the demand for stable isotope-labeled compounds in these sectors. Moreover, the significant investments made by pharmaceutical giants in research and development further reinforce their prominence in utilizing stable isotopes for innovative drug-related research, ultimately contributing to their high market share.

Competitive Landscape:

Major players operating in the global stable isotope labeled compounds market include: TAIYO NIPPON SANSO CORPORATION, PerkinElmer Inc., Alsachim, Isoflex, Merck KGaA, URENCO, 3C Molecular, Trace Sciences International, Cambridge Isotope Laboratories, Inc., IsoSciences, LLC, Medical Isotopes, Inc., and Omicron Biochemicals, Inc. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Global Stable Isotope Labeled Compounds Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Global Stable Isotope Labeled Compounds Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

• 1.1. Research Objective
• 1.2. Product Overview
• 1.3. Market Segmentation

2. Executive Summary

3. Global Stable Isotope Labeled Compounds Market Insights

• 3.1. Industry Value Chain Analysis
• 3.2. DROC Analysis
  • 3.2.1. Growth Drivers
    • 3.2.1.1. Increase in research activities in the pharmaceutical and biotechnology sectors
    • 3.2.1.2. Growing prevalence of diseases
  • 3.2.2. Restraints
    • 3.2.2.1. High cost of stable isotope labeled compounds
    • 3.2.2.2. Lack of skilled professionals
  • 3.2.3. Opportunities
    • 3.2.3.1. Pharmaceutical industry growth
    • 3.2.3.2. Emerging applications
  • 3.2.4. Challenges
    • 3.2.4.1. Production complexity
    • 3.2.4.2. Competition
• 3.3. Technological Advancements/Recent Developments
• 3.4. Regulatory Framework
• 3.5. Porter's Five Forces Analysis
  • 3.5.1. Bargaining Power of Suppliers
  • 3.5.2. Bargaining Power of Buyers
  • 3.5.3. Threat of New Entrants
  • 3.5.4. Threat of Substitutes
  • 3.5.5. Intensity of Rivalry

4. Global Stable Isotope Labeled Compounds Market Overview

• 4.1. Market Size & Forecast, 2019-2029
  • 4.1.1. By Value (USD Million)
• 4.2. Market Share and Forecast
  • 4.2.1. By Type
    • 4.2.1.1. Deuterium
    • 4.2.1.2. Oxygen-18
    • 4.2.1.3. Carbon-13
    • 4.2.1.4. Nitrogen-15
  • 4.2.2. By Application
    • 4.2.2.1. Medical Diagnostics
    • 4.2.2.2. Industrial
    • 4.2.2.3. Research
    • 4.2.2.4. Others
  • 4.2.3. By End User
    • 4.2.3.1. Academic & Research Institutions
    • 4.2.3.2. Hospital & Diagnostic Centers
    • 4.2.3.3. Pharmaceutical & Biotechnology Companies
    • 4.2.3.4. Others
  • 4.2.4. By Region
    • 4.2.4.1. North America
    • 4.2.4.2. Europe
    • 4.2.4.3. Asia Pacific (APAC)
    • 4.2.4.4. Latin America (LATAM)
    • 4.2.4.5. Middle East and Africa (MEA)

5. North America Stable Isotope Labeled Compounds Market

• 5.1. Market Size & Forecast, 2019-2029
  • 5.1.1. By Value (USD Million)
• 5.2. Market Share & Forecast
  • 5.2.1. By Type
  • 5.2.2. By Application
  • 5.2.3. By End User
  • 5.2.4. By Country
    • 5.2.4.1. United States
    • 5.2.4.1.1. By Type
    • 5.2.4.1.2. By Application
    • 5.2.4.1.3. By End User
    • 5.2.4.2. Canada
    • 5.2.4.2.1. By Type
    • 5.2.4.2.2. By Application
    • 5.2.4.2.3. By End User

6. Europe Stable Isotope Labeled Compounds Market

• 6.1. Market Size & Forecast, 2019-2029
  • 6.1.1. By Value (USD Million)
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Application
  • 6.2.3. By End User
  • 6.2.4. By Country
    • 6.2.4.1. Germany
    • 6.2.4.1.1. By Type
    • 6.2.4.1.2. By Application
    • 6.2.4.1.3. By End User
    • 6.2.4.2. United Kingdom
    • 6.2.4.2.1. By Type
    • 6.2.4.2.2. By Application
    • 6.2.4.2.3. By End User
    • 6.2.4.3. Italy
    • 6.2.4.3.1. By Type
    • 6.2.4.3.2. By Application
    • 6.2.4.3.3. By End User
    • 6.2.4.4. France
    • 6.2.4.4.1. By Type
    • 6.2.4.4.2. By Application
    • 6.2.4.4.3. By End User
    • 6.2.4.5. Spain
    • 6.2.4.5.1. By Type
    • 6.2.4.5.2. By Application
    • 6.2.4.5.3. By End User
    • 6.2.4.6. Belgium
    • 6.2.4.6.1. By Type
    • 6.2.4.6.2. By Application
    • 6.2.4.6.3. By End User
    • 6.2.4.7. Russia
    • 6.2.4.7.1. By Type
    • 6.2.4.7.2. By Application
    • 6.2.4.7.3. By End User
    • 6.2.4.8. The Netherlands
    • 6.2.4.8.1. By Type
    • 6.2.4.8.2. By Application
    • 6.2.4.8.3. By End User
    • 6.2.4.9. Rest of Europe
    • 6.2.4.9.1. By Type
    • 6.2.4.9.2. By Application
    • 6.2.4.9.3. By End User

7. Asia-Pacific Stable Isotope Labeled Compounds Market

• 7.1. Market Size & Forecast, 2019-2029
  • 7.1.1. By Value (USD Million)
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Application
  • 7.2.3. By End User
  • 7.2.4. By Country
    • 7.2.4.1. China
    • 7.2.4.1.1. By Type
    • 7.2.4.1.2. By Application
    • 7.2.4.1.3. By End User
    • 7.2.4.2. India
    • 7.2.4.2.1. By Type
    • 7.2.4.2.2. By Application
    • 7.2.4.2.3. By End User
    • 7.2.4.3. Japan
    • 7.2.4.3.1. By Type
    • 7.2.4.3.2. By Application
    • 7.2.4.3.3. By End User
    • 7.2.4.4. South Korea
    • 7.2.4.4.1. By Type
    • 7.2.4.4.2. By Application
    • 7.2.4.4.3. By End User
    • 7.2.4.5. Australia & New Zealand
    • 7.2.4.5.1. By Type
    • 7.2.4.5.2. By Application
    • 7.2.4.5.3. By End User
    • 7.2.4.6. Indonesia
    • 7.2.4.6.1. By Type
    • 7.2.4.6.2. By Application
    • 7.2.4.6.3. By End User
    • 7.2.4.7. Malaysia
    • 7.2.4.7.1. By Type
    • 7.2.4.7.2. By Application
    • 7.2.4.7.3. By End User
    • 7.2.4.8. Singapore
    • 7.2.4.8.1. By Type
    • 7.2.4.8.2. By Application
    • 7.2.4.8.3. By End User
    • 7.2.4.9. Vietnam
    • 7.2.4.9.1. By Type
    • 7.2.4.9.2. By Application
    • 7.2.4.9.3. By End User
    • 7.2.4.10. Rest of APAC
    • 7.2.4.10.1. By Type
    • 7.2.4.10.2. By Application
    • 7.2.4.10.3. By End User

8. Latin America Stable Isotope Labeled Compounds Market

• 8.1. Market Size & Forecast, 2019-2029
  • 8.1.1. By Value (USD Million)
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Application
  • 8.2.3. By End User
  • 8.2.4. By Country
    • 8.2.4.1. Brazil
    • 8.2.4.1.1. By Type
    • 8.2.4.1.2. By Application
    • 8.2.4.1.3. By End User
    • 8.2.4.2. Mexico
    • 8.2.4.2.1. By Type
    • 8.2.4.2.2. By Application
    • 8.2.4.2.3. By End User
    • 8.2.4.3. Argentina
    • 8.2.4.3.1. By Type
    • 8.2.4.3.2. By Application
    • 8.2.4.3.3. By End User
    • 8.2.4.4. Peru
    • 8.2.4.4.1. By Type
    • 8.2.4.4.2. By Application
    • 8.2.4.4.3. By End User
    • 8.2.4.5. Rest of LATAM
    • 8.2.4.5.1. By Type
    • 8.2.4.5.2. By Application
    • 8.2.4.5.3. By End User

9. Middle East & Africa Stable Isotope Labeled Compounds Market

• 9.1. Market Size & Forecast, 2019-2029
  • 9.1.1. By Value (USD Million)
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Application
  • 9.2.3. By End User
  • 9.2.4. By Country
    • 9.2.4.1. Saudi Arabia
    • 9.2.4.1.1. By Type
    • 9.2.4.1.2. By Application
    • 9.2.4.1.3. By End User
    • 9.2.4.2. UAE
    • 9.2.4.2.1. By Type
    • 9.2.4.2.2. By Application
    • 9.2.4.2.3. By End User
    • 9.2.4.3. Qatar
    • 9.2.4.3.1. By Type
    • 9.2.4.3.2. By Application
    • 9.2.4.3.3. By End User
    • 9.2.4.4. Kuwait
    • 9.2.4.4.1. By Type
    • 9.2.4.4.2. By Application
    • 9.2.4.4.3. By End User
    • 9.2.4.5. South Africa
    • 9.2.4.5.1. By Type
    • 9.2.4.5.2. By Application
    • 9.2.4.5.3. By End User
    • 9.2.4.6. Nigeria
    • 9.2.4.6.1. By Type
    • 9.2.4.6.2. By Application
    • 9.2.4.6.3. By End User
    • 9.2.4.7. Algeria
    • 9.2.4.7.1. By Type
    • 9.2.4.7.2. By Application
    • 9.2.4.7.3. By End User
    • 9.2.4.8. Rest of MEA
    • 9.2.4.8.1. By Type
    • 9.2.4.8.2. By Application
    • 9.2.4.8.3. By End User

10. Competitive Landscape

• 10.1. List of Key Players and Their Offerings
• 10.2. Global Stable Isotope Labeled Compounds Market Share Analysis, 2022
• 10.3. Competitive Benchmarking, By Operating Parameters
• 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Covid-19 on Global Stable Isotope Labeled Compounds Market

12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)

• 12.1. TAIYO NIPPON SANSO CORPORATION
• 12.2. PerkinElmer Inc.
• 12.3. Alsachim
• 12.4. Isoflex
• 12.5. Merck KGaA
• 12.6. URENCO
• 12.7. 3C Molecular
• 12.8. Trace Sciences International
• 12.9. Cambridge Isotope Laboratories, Inc.
• 12.10. IsoSciences, LLC
• 12.11. Medical Isotopes, Inc.
• 12.12. Omicron Biochemicals, Inc.
• 12.13. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

• 14.1. Qualitative Research
  • 14.1.1. Primary & Secondary Research
• 14.2. Quantitative Research
• 14.3. Market Breakdown & Data Triangulation
  • 14.3.1. Secondary Research
  • 14.3.2. Primary Research
• 14.4. Breakdown of Primary Research Respondents, By Region
• 14.5. Assumptions & Limitations